35 related articles for article (PubMed ID: 7861027)
1. Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells.
Fais S; Capobianchi MR; Silvestri M; Mercuri F; Pallone F; Dianzani F
J Interferon Res; 1994 Oct; 14(5):235-8. PubMed ID: 7861027
[TBL] [Abstract][Full Text] [Related]
2. Coordinate induction of IFN-alpha and -gamma by SARS-CoV also in the absence of virus replication.
Castilletti C; Bordi L; Lalle E; Rozera G; Poccia F; Agrati C; Abbate I; Capobianchi MR
Virology; 2005 Oct; 341(1):163-9. PubMed ID: 16095648
[TBL] [Abstract][Full Text] [Related]
3. Periodontal disease is associated with increased gut colonization of pathogenic Haemophilus parainfluenzae in patients with Crohn's disease.
Sohn J; Li L; Zhang L; Genco RJ; Falkner KL; Tettelin H; Rowsam AM; Smiraglia DJ; Novak JM; Diaz PI; Sun Y; Kirkwood KL
Cell Rep; 2023 Feb; 42(2):112120. PubMed ID: 36774550
[TBL] [Abstract][Full Text] [Related]
4. Concordant B and T Cell Heterogeneity Inferred from the Multiomic Landscape of Peripheral Blood Mononuclear Cells in a Crohn's Disease Cohort.
Brown M; Dodd A; Shi F; Greenwood E; Nagpal S; Kolachala VL; Kugathasan S; Gibson G
J Crohns Colitis; 2024 Apr; ():. PubMed ID: 38613150
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Molecular Drivers of Disease Heterogeneity in Crohn's Disease Using Multi-omic Data Integration and Network Analysis.
Sudhakar P; Verstockt B; Cremer J; Verstockt S; Sabino J; Ferrante M; Vermeire S
Inflamm Bowel Dis; 2021 May; 27(6):870-886. PubMed ID: 33313682
[TBL] [Abstract][Full Text] [Related]
6. Physical Activity Shapes the Intestinal Microbiome and Immunity of Healthy Mice but Has No Protective Effects against Colitis in MUC2
Estaki M; Morck DW; Ghosh S; Quin C; Pither J; Barnett JA; Gill SK; Gibson DL
mSystems; 2020 Oct; 5(5):. PubMed ID: 33024049
[TBL] [Abstract][Full Text] [Related]
7. The ETS transcription factor ELF1 regulates a broadly antiviral program distinct from the type I interferon response.
Seifert LL; Si C; Saha D; Sadic M; de Vries M; Ballentine S; Briley A; Wang G; Valero-Jimenez AM; Mohamed A; Schaefer U; Moulton HM; García-Sastre A; Tripathi S; Rosenberg BR; Dittmann M
PLoS Pathog; 2019 Nov; 15(11):e1007634. PubMed ID: 31682641
[TBL] [Abstract][Full Text] [Related]
8. Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases.
Abraham C; Dulai PS; Vermeire S; Sandborn WJ
Gastroenterology; 2017 Feb; 152(2):374-388.e4. PubMed ID: 27780712
[TBL] [Abstract][Full Text] [Related]
9. NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine.
Bai A; Moss A; Rothweiler S; Serena Longhi M; Wu Y; Junger WG; Robson SC
Nat Commun; 2015 Nov; 6():8819. PubMed ID: 26549640
[TBL] [Abstract][Full Text] [Related]
10. Experimental colitis is associated with transcriptional inhibition of Na+/Ca2+ exchanger isoform 1 (NCX1) expression by interferon γ in the renal distal convoluted tubules.
Radhakrishnan VM; Kojs P; Ramalingam R; Midura-Kiela MT; Angeli P; Kiela PR; Ghishan FK
J Biol Chem; 2015 Apr; 290(14):8964-74. PubMed ID: 25648899
[TBL] [Abstract][Full Text] [Related]
11. JAM-related proteins in mucosal homeostasis and inflammation.
Luissint AC; Nusrat A; Parkos CA
Semin Immunopathol; 2014 Mar; 36(2):211-26. PubMed ID: 24667924
[TBL] [Abstract][Full Text] [Related]
12. Intestinal barrier function: molecular regulation and disease pathogenesis.
Groschwitz KR; Hogan SP
J Allergy Clin Immunol; 2009 Jul; 124(1):3-20; quiz 21-2. PubMed ID: 19560575
[TBL] [Abstract][Full Text] [Related]
13. Intestinal epithelial CD98: an oligomeric and multifunctional protein.
Yan Y; Vasudevan S; Nguyen HT; Merlin D
Biochim Biophys Acta; 2008 Oct; 1780(10):1087-92. PubMed ID: 18625289
[TBL] [Abstract][Full Text] [Related]
14. Cytokines in inflammatory bowel disease.
Beck PL; Wallace JL
Mediators Inflamm; 1997; 6(2):95-103. PubMed ID: 18472842
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.
Ito R; Shin-Ya M; Kishida T; Urano A; Takada R; Sakagami J; Imanishi J; Kita M; Ueda Y; Iwakura Y; Kataoka K; Okanoue T; Mazda O
Clin Exp Immunol; 2006 Nov; 146(2):330-8. PubMed ID: 17034586
[TBL] [Abstract][Full Text] [Related]
16. A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease.
Reinisch W; Hommes DW; Van Assche G; Colombel JF; Gendre JP; Oldenburg B; Teml A; Geboes K; Ding H; Zhang L; Tang M; Cheng M; van Deventer SJ; Rutgeerts P; Pearce T
Gut; 2006 Aug; 55(8):1138-44. PubMed ID: 16492717
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma (IFN-gamma) and prostaglandin E2 (PGE2) regulate differently IL-12 production in human intestinal lamina propria mononuclear cells (LPMC).
Monteleone G; Parrello T; Monteleone I; Tammaro S; Luzza F; Pallone F
Clin Exp Immunol; 1999 Sep; 117(3):469-75. PubMed ID: 10469049
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 12 and Th1 responses in inflammatory bowel disease.
Pallone F; Monteleone G
Gut; 1998 Dec; 43(6):735-6. PubMed ID: 9824592
[No Abstract] [Full Text] [Related]
19. Interleukin-12 expression is focally enhanced in the gastric mucosa of pediatric patients with Crohn's disease.
Berrebi D; Besnard M; Fromont-Hankard G; Paris R; Mougenot JF; De Lagausie P; Emilie D; Cezard JP; Navarro J; Peuchmaur M
Am J Pathol; 1998 Mar; 152(3):667-72. PubMed ID: 9502407
[TBL] [Abstract][Full Text] [Related]
20. Inability of normal human intestinal macrophages to form multinucleated giant cells in response to cytokines.
Fais S; Pallone F
Gut; 1995 Dec; 37(6):798-801. PubMed ID: 8537050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
